The 2023 data on European government expenditure on R&D in medical and health sciences highlights Germany as the leader with €2.51 billion, followed by Spain and Italy. While countries like Portugal, Netherlands, Finland, and Baltic States allocate significantly less, variations indicate dynamic shifts. Germany and Slovakia saw substantial rises of over 10%, contrasting with declines in the Netherlands (7.53%) and Finland (4.3%). The 5-year CAGR showcases a growth trend in Germany and Slovakia, alongside moderate increases in Spain and Italy.
Future trends to watch include potential policy changes due to healthcare demands, economic constraints, or prioritization shifts, which may alter funding patterns across Europe.
Top countries in Government Expenditure on R&D in Medical and Health Sciences by Country
| # | 10 Countries | Million Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 2,510 | 2023 | +12.57% | +11.55% | View data |
| 2 | 2 Spain | 1,080 | 2023 | +4.27% | +5.12% | View data |
| 3 | 3 Italy | 858.76 | 2023 | +2.28% | +4.11% | View data |
| 4 | 4 Portugal | 65.35 | 2023 | +2.17% | +4.77% | View data |
| 5 | 5 Netherlands | 43.28 | 2023 | -11.87% | -7.53% | View data |
| 6 | 6 Finland | 29.06 | 2023 | -5.62% | -4.3% | View data |
| 7 | 7 Estonia | 24.9 | 2023 | +5.23% | +3.05% | View data |
| 8 | 8 Latvia | 12.78 | 2023 | +7.97% | +3.81% | View data |
| 9 | 9 Lithuania | 11.49 | 2023 | +2.81% | +2.67% | View data |
| 10 | 10 Slovakia | 9.07 | 2023 | +0.044% | +10.02% | View data |
